Richard Payerchin

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

A physician researcher discusses why primary care physicians do not participate in value-based payment models.

Monthly report shows gains for hospitals, home health care services.

How is life different across the pond? UK babies can expect to live longer than newborn Americans.

The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.

Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.

The Commonwealth Fund compares United States with other developed nations.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Lawmaker discusses state of the nation’s physician workforce – and the rise of part-time practice.

‘Old guys are taking ER call’ as younger docs ponder medicine as a calling, or just a job.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

The clock is ticking for lawmakers to approve policies that could affect U.S. health care.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Institutional leaders want to standardize practices, but flexibility may be a key to keeping doctors.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Proposals would require more public data on prior authorization processes and whether those advance health equity.

Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

News reports state RFK Jr. could take aim at codes recommended by the American Medical Association.

Commonwealth Fund examines underinsureds, now more than 20% of the people with health insurance around the country.

CMS Medicaid chief foreshadows potential policy changes coming when President-elect Trump moves into the White House.

Brooks-LaSure describes achievements in her final national leadership call.

How many people will be affected if Congress does not extend premium tax credits for ACA insurance?

Some states have few or no hospitals with ‘A’ grades for patient safety, according to the Leapfrog Group’s fall 2024 report card.

Leapfrog Group publishes fall 2024 marks for almost 3,000 facilities nationwide.

Antitrust chief says the nation is at an inflection point to restore competition or pay more money for less choice and more aggravation.

Study finds spreading medical misinformation is low on the list of reasons for disciplinary actions against physicians in recent years.